FRACTYL HEALTH, INC. - 10-Q Filing
Fractyl Health filed its 10-Q for the quarter ended March 31, 2026. The filing includes financial data and disclosures related to common stock warrants (Tranche A and Tranche B), an underwriting agreement with Ladenburg Thalmann & Co., Inc. for the August 2025 offering, employee stock purchase plans, fair value measurements of money market funds, and expenses from RevitaDirect and RejuvaDirect programs.
Tickers: $GUTS